Top Abstract Purchase Related
Home
>
Node
>
Subnode

Bacillus Calmette-Guérin and dinitrochlorobenzene immunotherapy of chemically induced bladder tumors

Lamm, D.L.; Harris, S.C.; Gittes, R.F.

Investigative Urology 14(5): 369-372

1977

ISSN/ISBN: 0021-0005
PMID: 844999
Document Number: 113621
Immunologic incompetence is correlated with increased susceptibility to malignacy. Immunostimulation with such agents as Bacillus Calmette-Guérin (BCG) and dinitrochlorobenzene (DNCB) have resulted in regression of cutaneous maligancies. An evaluation of the effect of BCG and dinitrochlorobenzene sensitization and bladder irrigation in Fischer rats revealed no decrease in the incidence of bladder tumors induced by 2-formylamino-4-(5-nitro-2-furyl) thiazole (FANFT). However, direct intralesional injection of BCG into early bladder tumors was effective in preventing the progression of such tumors in seven of ten BCG-sensitized rats (P less than 0.005). No effect was seen when BCG was injected intralesionally in unsensitized rats or when control solutions were injected.

Document emailed within 1 workday
Secure & encrypted payments

Flam, T.A.; Chopin, D.K.; Leleu, C.; Abbou, C.C.; Steg, A.; Deslignères, S.; Boccon-Gibod, L. 1990: Immunohistochemical markers defined by monoclonal antibodies and response to bacillus Calmette-Guérin endovesical immunotherapy for superficial bladder tumors European Urology 17(4): 338-342
Shapiro, A.; Ratliff, T.L.; Oakley, D.M.; Catalona, W.J. 1983: Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity Cancer Research 43(4): 1611-1615
De Boer, E.C.; De Jong, W.H.; Steerenberg, P.A.; Van der Meijden, A.P.; Aarden, L.A.; Debruyne, F.M.; Ruitenberg, E.J. 1991: Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin In Vivo 5(6): 671-677
Debruyne, F.M.; Witjes, J.A.; vd Meijden, A.P. 1990: Intravesical bacillus Calmette-Guérin (BCG) in superficial bladder tumors. An overview Archivos Espanoles de Urologia 43(Suppl): 133-138
Luo, Y.; Chen, X.; Downs, T.M.; DeWolf, W.C.; O'Donnell, M.A. 1999: IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy Journal of Immunology 162(4): 2399-2405
Moyano Calvo, J.L.; Sanz Sacristán, J.; Teba del Pino, F.; Fernández Arjona, M.; Peinado Ibarra, F.; Mélon Rey, F.; Herrero Torres, L.; Rabadán Ruiz, M.; Arellano Gañán, R.; Albacete Almodóvar, P. 1995: Calmette-Guerin bacillus in the prophylaxis of superficial bladder tumors. our experience and our doubts Archivos Espanoles de Urologia 48(8): 791-795
Iturralde Codina, A.; Beyríe Tamayo, W.; Gozá León, F.; Muñoz, Y.I. 2004: Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes Archivos Espanoles de Urologia 57(6): 606-618
Lee, P.P. 2015: Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations Annals of the Academy of Medicine Singapore 44(8): 297-301
Brosman, S.A. 1992: Bacillus Calmette-Guérin immunotherapy. Techniques and results Urologic Clinics of North America 19(3): 557-564
Merrin, C.; Han, T.; Klein, E.; Wajsman, Z.; Murphy, G.P. 1975: Immunotherapy of prostatic carcinoma with bacillus Calmette-Guerin Cancer ChemoTherapy Reports 59(1): 157-163
Houchens, D.P.; Goldberg, A.I.; Gaston, M.R.; Kende, M.; Goldin, A. 1973: Studies of the effects of Bacillus Calmette-Guérin on Moloney sarcoma virus-induced tumors in normal and immunosuppressed mice Cancer Research 33(4): 685-690
Okusa, H.; Irie, A.; Chin, I.; Baba, S.; Mitomi, H.; Shitara, T. 2003: Cases of bacillus Calmette-Guerin-induced granulomatous prostatitis and prostatic stromal invasion of the bladder carcinoma in situ, showing similar clinical findings Hinyokika Kiyo. Acta Urologica Japonica 49(9): 555-557
Sparks, F.C.; Breeding, J.H. 1974: Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase Cancer Research 34(12): 3262-3269
Vázquez-Lavista, L.G.; Flores-Balcázar, C.H.é; Llorente, L. 2007: The bacillus Calmette-Guérin as immunomodulator in bladder cancer Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 59(2): 146-152
Skaugen, P. 1997: Bacillus Calmette-Guerin therapy for bladder carcinoma in situ: use in a clinical setting Urologic Nursing 17(2): 69-71
Tsukagoshi, S. 2003: ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(7): 1027-1038
Nesher, G. 1999: Bacillus Calmette-Guérin induced reactive arthritis Journal of Rheumatology 26(7): 1638
Jurincic-Winkler, C.; Metz, K.A.; Beuth, J.; Sippel, J.; Klippel, K.F. 1995: Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guérin (BCG) instillation on carcinoma in situ of the urinary bladder Anticancer Research 15(6b): 2771-2776
Malhotra, I.; Mungai, P.; Wamachi, A.; Kioko, J.; Ouma, J.H.; Kazura, J.W.; King, C.L. 1999: Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis Journal of Immunology 162(11): 6843-6848
Nishino, Y.; Yasuda, M.; Yokoi, S.; Ehara, H.; Yamamoto, N.; Takahashi, Y.; Ishihara, S.; Deguchi, T.; Kawada, Y.; Takeda, A.; Sakai, S.; Takeuchi, T.; Taniguchi, M.; Minoshima, K.; Hamamoto, Y.; Kanimoto, Y.; Nakano, M.; Fujihiro, S.; Nezasa, S.; Matsuda, T.; Nagatani, Y.; Maeda, S.; Tamaki, M.; Saito, A.; Komeda, H. 1999: Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(12): 1869-1873